Blindness

"Blindness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Descriptor ID	D001766
MeSH Number(s)	C10.597.751.941.162 C11.966.075 C23.888.592.763.941.162
Concept/Terms	Blindness Blindness Blindness, Acquired Blindness, Acquired Acquired Blindness Blindness, Monocular Blindness, Monocular Monocular Blindness Blindness, Hysterical Blindness, Hysterical Hysterical Blindness Blindness, Transient Blindness, Transient Transient Blindness Blindness, Legal Blindness, Legal Legal Blindness Amaurosis Amaurosis Amauroses Blindness, Complete Blindness, Complete Complete Blindness

Below are MeSH descriptors whose meaning is more general than "Blindness".

Diseases [C]
Nervous System Diseases [C10]
Neurologic Manifestations [C10.597]
Sensation Disorders [C10.597.751]
Vision Disorders [C10.597.751.941]
Blindness [C10.597.751.941.162]
Eye Diseases [C11]
Vision Disorders [C11.966]
Blindness [C11.966.075]
Pathological Conditions, Signs and Symptoms [C23]
Signs and Symptoms [C23.888]
Neurologic Manifestations [C23.888.592]
Sensation Disorders [C23.888.592.763]
Vision Disorders [C23.888.592.763.941]
Blindness [C23.888.592.763.941.162]

Below are MeSH descriptors whose meaning is related to "Blindness".

Below are MeSH descriptors whose meaning is more specific than "Blindness".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Blindness" by people in this website by year, and whether "Blindness" was a major or minor topic of these publications.

Bar chart showing 116 publications over 28 distinct years, with a maximum of 15 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1997	1	1	2
1998	2	1	3
1999	2	0	2
2000	1	0	1
2001	5	0	5
2002	1	0	1
2003	2	0	2
2004	6	2	8
2005	2	1	3
2006	2	1	3
2007	0	2	2
2008	1	0	1
2009	3	2	5
2010	0	2	2
2011	3	2	5
2012	3	0	3
2013	3	3	6
2014	4	2	6
2015	9	1	10
2016	12	3	15
2017	3	2	5
2018	2	0	2
2019	7	1	8
2020	1	0	1
2021	2	3	5
2023	1	5	6
2024	0	2	2

Below are the most recent publications written about "Blindness" by people in Profiles.

Greenfield JA, Malek DA, Anant S, Antonietti M, Jammal A, Casella A, Miller SC, Wang K, Momenaei B, Lee K, Mansour HA, Justin GA, Makhoul KG, Bitar RA, Lorch AC, Armstrong GW, Wakabayashi T, Yonekawa Y, Woreta F, Cavuoto K. A multi-center analysis of visual outcomes following open globe injury. Sci Rep. 2024 07 18; 14(1):16638.

View in: PubMed
Cai CX, Nishimura A, Bowring MG, Westlund E, Tran D, Ng JH, Nagy P, Cook M, McLeggon JA, DuVall SL, Matheny ME, Golozar A, Ostropolets A, Minty E, Desai P, Bu F, Toy B, Hribar M, Falconer T, Zhang L, Lawrence-Archer L, Boland MV, Goetz K, Hall N, Shoaibi A, Reps J, Sena AG, Blacketer C, Swerdel J, Jhaveri KD, Lee E, Gilbert Z, Zeger SL, Crews DC, Suchard MA, Hripcsak G, Ryan PB. Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study. Ophthalmol Retina. 2024 Aug; 8(8):733-743.

View in: PubMed
Mehta NJ, Mehta SN. Nanotechnology in Retinal Disease: Current Concepts and Future Directions. J Ocul Pharmacol Ther. 2024 Jan-Feb; 40(1):3-12.

View in: PubMed
Lee KE, Thuma TBT, Wallingford M, Gunton KB, Schnall BM. Visual acuity improvement in the amblyopic eye of a 50-year-old man following strabismus surgery. J AAPOS. 2023 10; 27(5):303-305.

View in: PubMed
Marek S, Forbes G, Avery RA, Zanganeh T, Davidson S, DeCarlo E, Kumar P, Hammersmith K. Potential blindness from nutritional xerophthalmia in autistic patients. J AAPOS. 2023 08; 27(4):198.e1-198.e4.

View in: PubMed
Massenzio E, Xu D, Abishek R, Wibbelsman TD, Sheng Y, Obeid A, Bhatt S, Zhang Q, Sharpe J, Park CH, Spirn MJ, Gupta OP, Chiang A, Shukla A, Shalaby WS, Myers JS, Hsu J. RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST. Retina. 2023 07 01; 43(7):1150-1159.

View in: PubMed
Brant A, Kolomeyer N, Goldberg JL, Haller J, Lee CS, Lee AY, Lorch AC, Lum F, Miller JW, Parke DW, Hyman L, Pershing S. United States Population Disparities in Ophthalmic Care: Blindness and Visual Impairment in the IRIS? Registry (Intelligent Research in Sight). Ophthalmology. 2023 Nov; 130(11):1121-1137.

View in: PubMed
Zhao PY, Bommakanti N, Yu G, Aaberg MT, Patel TP, Paulus YM. Deep learning for automated detection of neovascular leakage on ultra-widefield fluorescein angiography in diabetic retinopathy. Sci Rep. 2023 06 06; 13(1):9165.

View in: PubMed
Chhabra N, Chiang CC, Di Nome MA, Houghton O, Carlin RE, O'Carroll CB, Dodick DW, Dumitrascu OM. Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine. Cephalalgia. 2022 05; 42(6):553-556.

View in: PubMed
Peck T, Patel SN, Mehta S. Severe Headaches in a Young Adult With Progressive Bilateral Vision Loss. JAMA Ophthalmol. 2021 10 01; 139(10):1141-1142.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement